Playing tailor-made video games can help children with attention deficit hyperactivity disorder (ADHD), according to results from a pivotal clinical trial announced on Monday.
The U.S. company developing the treatment, unlisted Akili, now plans to file for regulatory approval with the U.S. Food and Drug Administration in the first half of 2018.
Experts say it will paving the way for what would be the first such ‘digital’ prescription product.
Akili is an affiliate of London-listed PureTech Health.